Crystallization plays a pivotal role in the manufacturing of pharmaceuticals. This Comment briefly reflects on past achievements and emerging opportunities in industrial crystallization, particularly considering increasing molecular and system complexities.
This is a preview of subscription content, access via your institution
Access options
References
Cote, A. et al. Cryst. Growth Des. 20, 7568–7581 (2020).
Analysis Group for PhRMA Innovation in the Biopharmaceutical Pipeline (Pharmaceutical Research and Manufacturers of America, 2021).
dos Santos, R., Carvalho, A. L. & Roque, A. C. A. Biotechnol. Adv. 35, 41–50 (2017).
Puhl, S., Meinel, L. & Germershaus, O. Asian J. Pharm. Sci. 11, 469–477 (2016).
Verma, V., Bade, I., Karde, V. & Heng, J. Y. Y. Pharmaceutics 15, 1288 (2023).
Chen, W. et al. Cryst. Growth Des. 20, 866–873 (2020).
Li, X. & Heng, J. Y. Y. Chem. Eng. Res. Des. 173, 81–88 (2021).
Li, X. & Heng, J. Y. Y. CrystEngComm 23, 8386–8391 (2021).
Capellades, G., Bonsu, J. O. & Myerson, A. S. CrystEngComm 24, 1989–2001 (2022).
Nordstrom, F. L. et al. Org. Process Res. Dev. 27, 723–741 (2023).
Simon, L. L. et al. Org. Process Res. Dev. 19, 3–62 (2015).
Xiouras, C. et al. Chem. Rev. 122, 13006–13042 (2022).
Lovette, M. A. et al. Cryst. Growth Des. 22, 5239–5263 (2022).
Landis, S., Zhao, Y. & Doherty, M. F. Comput. Chem. Eng. 133, 106637 (2020).
Richard, A. M. Chem. Res. Toxicol. 19, 1257–1262 (2006).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kocevska, S., Burcham, C.L., Nordstrom, F. et al. A changing paradigm in industrial pharmaceutical crystallization. Nat Chem Eng 1, 327–329 (2024). https://doi.org/10.1038/s44286-024-00068-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44286-024-00068-8
